The influence of activation of the ATP-sensitive potassium channels by flocalin on the function of the cardiovascular system
Strutyns'kyĭ RB, Rovenets' RA, Strutyns'ka NA, Neshcheret OP, Moĭbenko OO
O.O. Bogomoletz Institute of Physiology National Academyof Science of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz59.01.011
Abstract
In experiments on the anaesthetized dogs the influence of a new fluorine-containing opener of ATP-sensitive potassium (K(ATP)) channels flocalin on the cardiohemodynamic of great animals in vivo was studied. Flocalin introduced intravenously in doses 0.01 - 1.5 mgs/kg. It is shown that it reduces in dose-dependent manner a system arterial pressure, perfusion pressure in coronary artery and general peripheral resistance of vessels with maximal effects on 56.8 +/- 2.7, 22.4 +/- 4.7 and 47.2% +/- 6.5% accordingly at most dose 1.5 mgs/kg. Flocalin causes development of cardiodepressive reactions in heart, that is exhibited in dose-dependent the decrease of pressure in the left ventricle, speed of growth (dP/dt(max)) and reduction (dP/dt(min)) in it's of pressure with maximal effects on 37.1 +/- 5.1, 51.2 +/- 9.4 and 55.6% +/- 6.9% accordingly at introduction of most dose of flocalin. Diminish of the cardiac out put and heart rate with a maximal effects on 23.1% +/-12.7% and 19.2% +/- 1.7% accordingly at a dose 1.0 mgs/kg was shown. It should be noted that considerable reduction of heart rate and general peripheral resistance of vessels takes place only at the large doses of flocalin - 1 and 1.5 mgs/kg. Thus, it is shown that activation of K(ATP) channels by flocalin causes the dose-dependent decrease of pressure in the system of circulation of blood and contraction activity of myocardium.
Keywords:
KATP channels, flocalin, сardiohemodynamic, diminishing of vascular pressure, cardiodepressive reactions
References
- Burbello A.T., Shabrov A.V., Denisenko P.P. Sovre mennie lukarstvennie sredstva. Kliniko-farmakologicheskii spravochnik prakticheskogo vracha . Neva, Sank-Peterburg, M.; 2006. 896 p.
- Gurevich M.I., Povzhitkov M.M. Metodi issledovaniya serdechnogo vibrosa i nekotorie aspekti ego regulyatsii. V kn.: Gemodinamika i perifericheskoe krovoobrashchenie. K., 1968. P.3-26.
- Moibenko O.O., Strutins'kii R.B., Yagupol's'kii L.M., Mohort M.A. Rozrobka ta pidgotovka do vprovadzhennya novogo vitchiznyanogo kardioprotektornogo preparatu ftorvmisnogo aktivatora ATF-zalezhnih kaliievih kanaliv flokalin . Nauka ta innovatsii. 2006. 2, N 4. P.77-82.
- Moibenko O.O., Strutins'kii R.B., Yagupol's'kii L.M., Mohort M.A., Shalamai A.S. Organizatsiya promislovogo vigotovlennya preparatu Flokalin novogo vitchiznyanogo miotropnogo spazmolitika i kardioprotektora . Tam samo. 2009. 5, N 1. P.80-84.
- Pivovar S.M. Endogenni mehanizmi kardioprotektsii: Rol' aktivatsii mitohondrial'nih ATF-chutlivih kaliievih kanaliv. Avtoref. kand. dis. 2006. 20 p.
- Strutins'kii R.B., Kotsyuruba A.V., Neshcheret O.P., Rovenets' R.A., Moibenko O.O. Zmini metabolizmu v miokardi pri ishemii-reperfuzii ta aktivatsii adenozintrifosfatchutlivih kaliievih kanaliv . Fiziol.zhurn. 2012.- 58, N 1 P.13-26.
- Strutins'kii R.B., Kotsyuruba A.V., Neshcheret O.P., Shish A.M., Rovenets' R.A., Moibenko O.O. Kardioprotektorni efekti aktivatsii adenozintrifosfatzalezhnih kaliievih kanaliv v eksperimentah in vivo: vpliv na biohimichni parametri krovi za umov ishemii-reperfuzii miokarda . Tam samo. 2009. 55, N 6. P.12-19.
- Strutins'kii R.B., Moibenko O.O., Yagupol's'kii L.M. Doslidzhennya vazomotornih efektiv novih ftorvmistnih sintetichnih aktivatoriv ATF-zalezhnih kaliievih kanaliv. . Tam samo. 2000. 46, N 4. P.17-23.
- Strutins'kii R., Mohort M., Yagupol's'kii L., Moibenko O. Flokalin novii vitchiznyanii kardioprotektor . Visnik farmakologii ta farmatsii. 2010. N 3. P.44-56.
- Strutinskii R.B., Pivovar S.N., Rovenets R.A., Piskun O.V., Yagupol's'kii L.M., Moibenko O.O. Vpliv aktivatora adenozintrifosfatchutlivih kaliievih kanaliv flokalinu na funktsionuvannya izol'ovanogo sertsya . Fiziol. zhurn. 2005. 51, N 6, P.18-24.
- Strutins'kii R.B., Rovenets' R.A., Neshcheret O.P., Tumanovs'ka L.V., Boichuk T.M., Dzhuran B.V., Moibenko O.O. Vpliv likars'koi formi flokalinu na perebig shemii-reperfuzii miokarda . Tam samo. 2011. 57, N 1. P. 55-65.
- Eells J.T., Henry M.M., Gross G.J., Baker J.E. Increased mitochondrial KATP channel activity during chronic myocardial hypoxia. Is cardioprotection mediated by improved bioenergetics? . Circ Res. 2000. 87, N 10. P.915-921.
CrossRef
PubMed
- Gross G.J., Fryer R.M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning . Ibid. 1999. 84, N 9. P.973-979.
CrossRef
- Grover G.J., Baird A.J., Sleph P.G. Lack of pharmacologic interaction between ATP-sensitive potassium channels and adenosine A1 receptors in ischemic rat hearts . Cardiovasc Res. 1996. 31, N 4. P.511-517.
CrossRef
- Strutynskyi R.B. Vasodilatation Effects of Fluorine- Containing KATP Channels Opener of Flocalin . Int. J. Phys. Pathophys. 2011. 2, N 1. P. 69-77.
CrossRef
- Voitychuk O.I., Strutynskyi R.B., Moibenko O.O., Shuba Y.M. Effects of uorine-containing opener of ATP-sensitive potassium channels, pinacidil-derivative ocalin, on cardiac voltage-gated sodium and calcium channels . NSAP. 2012. 385, N 11. P. 1095-1102.
CrossRef
PubMed
- Voitychuk O.I., Strutynskyi R.B., Yagupolskii L.M., Tinker A., Moibenko O.O., Shuba Y.M. Sarcolemmal cardiac KATP channels as a target for the cardioprotective effects of the uorine-containing pinacidil analogue ocalin . Brit. J. Pharmacol. 2011. 162, N 3. P. 701-711.
CrossRef
PubMed PubMedCentral
- Yokoshiki H., Sunagawa M., Seki T., Sperelakis N. ATP- sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells . Amer. J. Physiol. Cell. Physiol. 1998. 274. P. 25-37.
CrossRef
|